Rivastigmine
ریواستیگمین
🧠 Nervous SystemCholinesterase inhibitor
Market / country: 🇺🇸 USA
Exelon (US)
🧮 Dose calculator
Alzheimer's disease · Regimen source: FDA Rivastigmine caps. · 2.1
- • At least every 2 weeks: 3 → 4.5 → 6 mg twice daily. If interrupted >3 days restart at 1.5 mg. With food. FDA Rivastigmine caps. · 2.1FDA Rivastigmine caps. · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to rivastigmine or carbamates; previous patch-site reaction. FDA Rivastigmine caps. · 4
Formulations
- 1.5 mg capsule — capsule 🇺🇸 USA FDA Rivastigmine caps. · 3
- 3 mg capsule — capsule 🇺🇸 USA FDA Rivastigmine caps. · 3
- 4.5 mg capsule — capsule 🇺🇸 USA FDA Rivastigmine caps. · 3
- 6 mg capsule — capsule 🇺🇸 USA FDA Rivastigmine caps. · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Rivastigmine caps. · 8.1
“Risk Summary There are no adequate data on the developmental risks associated with the use of rivastigmine tartrate in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Rivastigmine caps. · 8.2
“Risk Summary There are no data on the presence of rivastigmine in human milk, the effects on the breastfed infant, or the effects of rivastigmine on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Rivastigmine caps. · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Rivastigmine caps. · 8.5
“Of the total number of patients in clinical studies of rivastigmine tartrate, 86% were 65 years and older while 46% were 75 years and older.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA204572
- DailyMed (FDA label)FDA Rivastigmine caps.
- MedlinePlus (NIH)RivastigmineRivastigmine Transdermal Patch
- WHO ATC/DDDN06DA03
- Darooyab (Iran)Rivastigmine
🇮🇷 Registered in Iran Darooyab · G-3054/Rivastigmine
Dosage forms with Iranian generic codes, per Darooyab.
- 01998 · RIVASTIGMINE 1.5MG CAP · کپسول ریواستیگمین ۱٫۵ میلیگرم
- 01902 · RIVASTIGMINE 1.5MG TAB · قرص ریواستیگمین ۱٫۵ میلیگرم
- 15859 · RIVASTIGMINE 18MG/10CM2 PATCH · پچ پوستی ریواستیگمین ۱۸ میلیگرم / ۱۰ سانتیمتر ۲
- 09689 · RIVASTIGMINE 2MG/100ML SYRUP · شربت ریواستیگمین ۲ میلیگرم / ۱۰۰ میلیلیتر
- 01999 · RIVASTIGMINE 3MG CAP · کپسول ریواستیگمین ۳ میلیگرم
- 01903 · RIVASTIGMINE 3MG TAB · قرص ریواستیگمین ۳ میلیگرم
- 02000 · RIVASTIGMINE 4.5MG CAP · کپسول ریواستیگمین ۴٫۵ میلیگرم
- 01904 · RIVASTIGMINE 4.5MG TAB · قرص ریواستیگمین ۴٫۵ میلیگرم
- 19832 · RIVASTIGMINE 4.6MG/24H PATCH · پچ پوستی ریواستیگمین ۴٫۶ میلیگرم / ۲۴ H
- 02738 · RIVASTIGMINE 6MG CAP · کپسول ریواستیگمین ۶ میلیگرم
- 01931 · RIVASTIGMINE 6MG TAB · قرص ریواستیگمین ۶ میلیگرم
- 15858 · RIVASTIGMINE 9MG/5CM2 PATCH · پچ پوستی ریواستیگمین ۹ میلیگرم / ۵ سانتیمتر ۲
- 52413 · RIVASTIGMINE (AS HYDROGEN TARTRATE) SOLUTION ORAL 2 mg/1mL 120 mL · محلول خوراکی ریواستیگمین (معادل هیدروژن تارتارات) ۲ میلیگرم / ۱ میلیلیتر ۱۲۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Rivastigmine caps. · 3FDA Rivastigmine caps. · 2.1FDA Rivastigmine caps. · 2.3FDA Rivastigmine caps. · 4FDA Rivastigmine caps. · 8.1FDA Rivastigmine caps. · 8.2FDA Rivastigmine caps. · 8.4FDA Rivastigmine caps. · 8.5FDA Rivastigmine caps. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3054/Rivastigmine
- Clinical review⚠ Unverified